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Abstract
CSDE1 encodes the cytoplasmic cold shock domain-containing protein E1 (CSDE1),
which is highly conserved across species and functions as an RNA-binding protein
involved in translationally coupled mRNA turnover. CSDE1 displays a bidirectional
role: promoting and repressing the translation of RNAs but also increasing and
decreasing the abundance of RNAs. Preclinical studies highlighted an involvement of
CSDE1 in different forms of cancer. Moreover, CSDE1 is highly expressed in human
embryonic stem cells and plays a role in neuronal migration and differentiation. A
genome-wide association study suggested CSDE1 as a potential autism-spectrum dis-
order risk gene. A multicenter next generation sequencing approach unraveled likely
causative heterozygous variants in CSDE1 in 18 patients, identifying a new autism
spectrum disorder-related syndrome consisting of autism, intellectual disability, and
neurodevelopmental delay. Since then, no further patients with CSDE1 variants have
been reported in the literature. Here, we report a 9.5-year-old girl from a consanguin-
eous family of Turkish origin suffering from profound delayed speech and motor
development, moderate intellectual disability, neurologic and psychiatric symptoms
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as well as hypoplasia of corpus callosum and mildly reduced brain volume on brain
magnetic resonance imaging associated with a recurrent de novo mutation in CSDE1
(c.367C > T; p.R123*) expanding the phenotypical spectrum associated with patho-
genic CSDE1 variants.
K E YWORD S
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and cry
1 | INTRODUCTION
CSDE1 encodes the cytoplasmic cold shock domain-containing
protein E1 (CSDE1), which is highly conserved across species (Guo
et al., 2019). CSDE1 functions as an RNA-binding protein involved
in translationally coupled mRNA turnover (Chang et al., 2004) and
is required for efficient formation of stress granules (Youn
et al., 2018). Interestingly, CSDE1 displays a bidirectional role: pro-
moting and repressing the translation of RNAs but also increasing
and decreasing the abundance of RNAs (Guo et al., 2020;
Kakumani et al., 2020). Ju Lee and co-workers demonstrated that
CSDE1 is highly expressed in human embryonic stem cells (hESCs)
and post-transcriptionally modulates core components of multiple
regulatory nodes of hESC identity and neurogenesis (Ju Lee
et al., 2017). Hence, CSDE1 has been implicated in both neuronal
migration and differentiation (Ju Lee et al., 2017; Kobayashi
et al., 2013) and a genome-wide association study suggested
CSDE1 as a potential autism-spectrum disorder (ASD) risk gene
(Xia et al., 2014). Indeed, a multicenter next generation sequencing
(NGS) approach unraveled likely causative heterozygous variants
in CSDE1 in 18 patients, identifying a new ASD-related syndrome
(Guo et al., 2019). The most consistent phenotypes include a com-
bination of ASD, intellectual disability, delayed speech, and del-
ayed motor development. Half of the patients reported in this
study presented with varied abnormalities on brain magnetic reso-
nance imaging (MRI), for example, thin or short corpus callosum,
white matter alterations with resulting prominent ventricular sys-
tem, thickened cortex, and mild cerebellar vermis hypoplasia.
Along this line, in vitro and in vivo functional analyses highlight the
important role of Csde1 in neuronal development and synaptic
transmission (Guo et al., 2019).
Here, we report on a girl born to consanguineous parents of
Turkish origin suffering from delayed speech and motor develop-
ment, moderate intellectual disability, neurologic symptoms,
psychiatric symptoms and hypoplasia of corpus callosum and
mildly reduced brain volume on brain MRI associated with a de
novo mutation in the CSDE1 gene (c.367C > T; p.R123*,
ENST00000369530) already reported three times in the litera-
ture as pathogenic (Guo et al., 2019). However, although this
variant seems to be the most recurrent pathogenic dominant var-
iant in CSDE1 identified thus far, muscle weakness, as present in
our patient, has not been linked to the phenotypical spectrum of
this disease before.
2 | MATERIALS AND METHODS
2.1 | Editorial policies and ethical considerations
Written informed consent for all diagnostic steps as well as the per-
mission to publish clinical data and photographs were obtained from
both parents and the ethics committee of University Medicine Essen
(19-9011-BO, February 4, 2020) had granted ethical approval. The
study was conducted in accordance with the principles of the Declara-
tion of Helsinki of 1975, as revised in 1983.
2.2 | Genetic analyses
In the genetic work-up, first regular karyotyping was performed followed
by array-based comparative genomic hybridization (CGH). Under the sus-
picion of an autosomal recessive disorder, a trio exome sequencing was
carried out. Whole exome sequencing (WES) was performed by the Geno-
mics Platform at the Broad Institute of MIT and Harvard, Cambridge, USA.
Libraries were created with an Illumina exome capture (38 Mb target) and
sequenced with a mean target coverage of >80x. Exome sequencing data
were processed and analyzed on the RD-Connect Genome-Phenome
Analysis Platform (https://platform.rdconnect.eu/genomics). Likely patho-
genic variants were identified applying standard filtering criteria: minor
allele frequency <1% and high-to-moderate variant effect predictor. Sho-
rtlisted variants were interrogated for their predicted in silico deleterious-
ness and previous known association with human disease.
3 | CLINICAL REPORT
The female patient is the third child of healthy, consanguineous parents
(cousins I) of Turkish origin. Family history is unremarkable (the 16-
and 19-year-old brothers showed normal development) (see Figure 1a).
Parental age at conception was 34 (father) and 32 (mother). Pregnancy
was uneventful with unremarkable findings on prenatal ultrasound
screening and the mother reported normal fetal movements.
3.1 | 0–4 weeks (newborn)
Spontaneous delivery was at term (38 weeks of pregnancy) with nor-
mal birth measurements (weight: 3790 g [93. percentile, 1.45z],
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length: 50 cm [43. percentile, 0.17z], head circumference: 35 cm
[71. percentile, 0.54z]) (percentiles from: Voigt et al., 2006) and Apgar
10 9, 50 10, 100 10. Due to mild hyperbilirubinemia, phototherapy was
performed on fifth day of life.
3.2 | 1–12 months of age (infant)
The patient was breastfed for 6 months and thrived well. At preven-
tive medical check-ups with 4 weeks, 3 and 6 months, no abnormali-
ties were recorded by the pediatrician. At the age of 12 months, it
was noted that she was neither able to crawl coordinated nor to sit
without help and did not try to pull herself up.
3.3 | 1–2 years of age (toddler)
The patient was presented at our department for the first time at the
age of 24 months due to the above-mentioned neurodevelopmental
delay. Motor milestones were significantly delayed: she learned to sit
without assistance at the age of 14 months and was able to move
around by sliding on her bottom and walking along furniture by
23 months. These milestones were achieved with the help of the early
support (“Frühförderung”) she received from the age of 21 months.
At the age of 24 months, she was still not able to pull herself
up. Besides gross motor delay, fine motor abilities were also delayed,
not being able to complete simple puzzles at the age of 24 months.
The patient was raised bilingual (Turkish/German) and was only able
to speak eight Turkish words (no two-word-sentences) at the age of
24 months. Additionally, parents reported problems chewing and
swallowing small pieces of food, porridge was still preferred. Due to
the neurodevelopmental delay, basic diagnostic work-up was per-
formed at the age of 2 years and 7 months: brain MRI (Figure 1b I–III)
showed mildly reduced brain volume with moderate dilation of the
ventricular system, slight enlargement of prefrontal subarachnoid
space, slim white matter, and a thin and short corpus callosum with a
partial lack of the splenium. However, myelination and gyration were
adequately developed for the child's age. Chromosome analysis rev-
ealed a normal female karyotype (46, XX), ultrasound of the abdomen,
echocardiography, electroencephalography, standard laboratory
F IGURE 1 (a) Family Pedigree: I.1 and I.2: Healthy,
consanguineous parents (cousins I) of Turkish Origin. II.1: CSDE1
patient (index), II.2: 16-year-old healthy brother II.3: 19-year-old
healthy brother. (b) I.-III.: Brain MRI at the age of 3: mildly reduced
brain volume with moderate dilation of the ventricular system, slight
enlargement of prefrontal subarachnoid space, slim white matter, and
a thin and short corpus callosum with a partial lack of the splenium.
I. T1 transversal, II. T2 transversal, III. T1 sagittal, IV.-VI.: Brain MRI at
the age of nine: Signs of a mildly reduced brain volume, but some
further development to normality with a slight decrease of the
ventricular dilation and a normalization of the size of the prefrontal
subarachnoid space. The corpus callosum remains thin and short with
a partial lack of the splenium. IV. T1 transversal, V. T2 transversal,
VI. T1 sagittal. (c) Photographs of our CSDE1 patient at the age of
8 years and 6 months, I. from front, II. from side, and III. from behind.
The patient started crying with joy when asked about her watch, only
to cry again because of anxiety due to the examination and cried
throughout the whole examination, unable to stop. Note the
hypotonia of the trunk, plantigrade footrest, internal rotation, and
deviating foot axis of the left foot
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evaluations and basic metabolic work-up (plasma and cerebrospinal
fluid) showed no abnormalities.
3.4 | 3–5 years of age (preschooler)
Motor and speech development remained delayed, but continuous
developmental progress was noted by the parents. Independent walk-
ing was achieved at 3 years and 10 months, she was still only able to
speak some single words, but speech comprehension improved. Clini-
cal examination showed no dysmorphisms, the patient was shy but
friendly, did not speak with the examiner. Her gait was broad based
and a bit unsteady. Under suspicion of a neuropathy, nerve conduc-
tion velocities were performed with normal results. Mild ataxia was
seen when reaching for objects. To exclude ataxia telangiectasia
alpha-fetoprotein was measured and showed a normal result. Getting
up from supine to sitting and getting up from floor was not possible,
respectively.
At the age of 3 years and 11 months, a testing via Bayley-Scales
of Infant Development II (Bayley II) was performed (Snijders Oomen
non-verbal intelligence test [SON-R] and Kaufman Assessment Bat-
tery for Children [K-ABC] not being possible to be performed due to
the neurodevelopmental delay) revealing a delay of 2 years (cognitive-
verbal developmental age: 22 months).
At the age of 4 years 8 months, parents reported further
developmental progress, meaning her gait being a bit more stable.
They reported problems climbing stairs and getting up from floor.
At this age, she was able to speak a maximum of 20 words in
single-word-sentences. Clinical examination showed no further
evidence for ataxia. Performance of an array-based CGH showed
a normal result, with additionally reported large homozygous
regions.
At the age of 5 years and 11 months, parents reported a persis-
tent lack of independence in eating/drinking, toileting, and dressing.
The patient was now able to get up from supine to sitting without
help but needed still support to get up from floor. She was shy but
friendly and able to understand simple commands of the examiner
and put them into practice. Patellar tendon reflexes were vivid with
enlarged reflex zones.
3.5 | 6–10 years of age (school-aged child)
At the age of 6 years and 11 months, the SON-R intelligence test was
possible to be performed and showed an intelligence quotient of
50 (normal range 85–115), with scale of action 50 and scale of
thought 50. Additionally, the general scale of speech of the Wechsler
Preschool and Primary Scale of Intelligence (WPPSI-III) was done and
showed a result of 45 (normal range 85–115). Parents reported slight
motor progress, now being able to walk 30 min and learning to crawl.
She was still not able to get up from floor, neither to sit down all by
herself. She was only able to climb stairs by herself but not to
descend; in this case, she needed to be carried by her parents. She
was still dependent on her parents in all tasks concerning daily life.
Clinical examination revealed a truncal muscle hypotonia and finger
tapping was mildly ataxic.
At the age of 8 years and 3 months, the parents did not report
further developmental progress, but they mentioned her being
interested in toys and loving to play with her dolls. She was going
to a special school with focus on mental development and made
friends there. At this examination, she did not cooperate very well,
was very shy and started crying immediately. The patient was still
not able to get up and sit down all by herself. An intermittent
action tremor was observed, the gait was abnormal with planti-
grade footrest, internal rotation of the left foot, spindly with broad
base. Additionally, clonus of both feet (right > left) and muscular
hypotonia of the trunk were notable. Deep tendon reflexes were
laterally identical, vividly triggerable. Electrophysiological studies
were not performed.
At the age of 8 years and 6 months, parents reported additional
features concerning her emotional state. They described her as a very
anxious child, having frequently changing moods, crying very often as
reaction to anxiety as well as to happiness. This was confirmed during
the clinical examination (Figure 1c I–III), where she started crying with
joy when asked about her watch, only to cry again because of anxiety
due to the examination. She cried throughout the whole examination,
unable to stop. Due to the new symptoms (intention tremor, clonus,
abnormal gait, and mood changes) additional diagnostic work-up was
performed. Brain MRI was repeated, showing some further develop-
ment to normality with a slight decrease of the ventricular dilation
and a normalization of the size of the prefrontal subarachnoid space.
The corpus callosum, however, remained thin and short with a partial
lack of the splenium and there were still signs of a mildly reduced
brain volume (Figure 1b IV–VI). MRI of the spinal cord was comple-
mented, showing normal results. Additionally, trio exome sequencing
was initiated.
At her last appointment, the patient was 10 years and 4 months
old. She was finally able to get up all by herself. In the meantime, she
had been fitted with foot orthoses to improve her gait and a wheel-
chair due to exercise intolerance. She was still only able to speak a
few words with her parents, verbal communication with the examiner
was not possible. She vacillated between anxiety and laughter. The
body measurements were within the normal range (weight 43.5 kg
[85. percentile], height 138.6 cm [25. percentile], body mass index
22.6 kg/m2 [95. percentile] (percentiles from: Kromeyer-Hauschild
et al., 2001), head circumference 51.5 cm [15. percentile] (percentiles
from: Braegger et al., 2011). She still showed truncal hypotonia and
abnormal gait with hardly any rolling movement of the left foot, due
to reduced range of motion of left upper ankle and foot deformity
(bending foot on the right, hollow and sickle foot on the left) causing
significantly increased load on the outer foot edges and internal rota-
tion of the left foot. Clonus was still present in her right upper ankle
join. Lifting the head from a lying position was possible, getting up
from the floor was done cumbersome, first via the side and then via
the four-footed stand, finally pulling herself up with the help of the
examination bench.
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4 | RESULTS
Regular karyotyping (46, XX) and array based CGH were normal, the
second revealing additionally reported large homozygous regions. Trio
exome sequencing showed a heterozygous de novo nonsense
variant in the CSDE1 gene (HGNC: 29905): c.367C>T; p.R123*,
ENST00000369530. This high effect impact is expected to result in
absent protein due to the premature stop gain and annotated as dis-
ease causing by Mutation Taster but displays a CADD score of 36.
This change is absent from all the control populations (1000 genomes
project and GnomAD database; http://gnomad.broadinstitute.org/).
The chromosomal position based on hg38 coordinates is:
chr1:114738043 G>A.
A search for homozygous variants across the whole exome of this
patient retrieves a total of 12 variants. Of these, three genes (ARMC4,
CEP290, and CA5A) are associated with human disease, yet none of
them explains the phenotype of the patient.
5 | DISCUSSION
Here, we report on the development of the neuropediatric phenotype
in a girl carrying a de novo p.R123* nonsense variant in CSDE1. Given
that this pathogenic variant was already reported three times in litera-
ture, one might speculate that it represents a recurrent—so far even
the most frequent—variant associated with the CSDE1-related pheno-
type. The addition of our case might suggest that this is a mutational
hotspot.
Interestingly, Guo and colleagues describe in total 18 patients
with CSDE1 variants, of whom eight are de novo, eight inherited (five
paternally and three maternally) and two with undetermined inheri-
tance. This finding is most likely explained by incomplete penetrance.
The p.R123* variant was de novo twice and maternally inherited once
(Guo et al., 2019). The fact that the nonsense variant is de novo in our
patient in combination with the fitting phenotype, suggests a patho-
genicity of this particular variant in a dominant pattern. Nevertheless,
longitudinal studies of CSDE1 families, including more detailed pheno-
typic and genetic assessment of carriers, are needed to better under-
stand the progression and risk factors associated with variable
expression of this disorder.
The clinical longitudinal study of our patient revealed some con-
cordance in the core features (neurodevelopmental delay and ID) pre-
viously described by Guo and colleagues about 18 patients with likely
disease-causing variants in CSDE1. In their report, neu-
rodevelopmental delay and intellectual disability were found in 17 out
of 17 patients and autism was observed in 11 out of 17 patients (Guo
et al., 2019) but was in contrast, not diagnosed in our patient. How-
ever, she showed some accompanying psychological symptoms often
associated with autism, like increased anxiety (7/17 patients reported
by Guo and colleagues) (Guo et al., 2019), peculiarities in the percep-
tion and processing of environmental and sensory stimuli, getting her
into situations of sensory overload resulting in pathological laughter
and crying. Further symptoms reported by Guo and colleagues (Guo
et al., 2019) like epilepsy/EEG abnormalities, macrocephaly, sleep dis-
turbances, behavioral problems (repetitive, obsessive, self-injurious or
aggressive behavior/attention deficit hyperactivity disorder), eye
abnormalities, recurrent infections, hand deformity, and short stature
were not present in our patient.
Our patient showed additional neurological symptoms expanding
the phenotype associated with CSDE1 by adding signs of muscle
weakness (not able to get up from floor until the age of 9 years and
exercise intolerance), increased tone at the upper ankle joints and clo-
nus (pyramid track sign), abnormal gait (gait instability requiring foot
orthoses), and intention tremor (cerebellar sign). A similar severity of
motor delay was reported very recently by El Khouri and colleagues,
who described a patient with a nearby located CSDE1 variant
(c.362C>A; p.S121*), who was not able to walk independently until
the age of 8, showed an ataxic gait thereafter, as well as additionally
pronounced facial dysmorphisms, repetitive behavior associated with
severe ID and absence of speech but normal MRI of the brain
(El Khouri et al., 2021).
MRI of the brain (performed twice) of our patient showed mildly
reduced brain volume with moderate dilation of the ventricular sys-
tem, slight enlargement of prefrontal subarachnoid space, slim white
matter and a thin and short corpus callosum with a partial lack of the
splenium. This is consistent with the findings of Guo and colleagues,
who reported in 7 out of 17 patients abnormalities on brain MRI, for
example, prominent ventricular system in five patients, thin corpus
callosum in two patients, vermis hypoplasia in two patients and white
matter alterations in one patient. Interestingly, the two patients with
thin corpus callosum were not the ones with the same variant
(Table 1), which suggests that this is not a variant-specific abnormal-
ity, but is generally attributable to mutations in CSDE1 as well as in
autism in general (Wegiel et al., 2017). Hence, a comparison of our
patient with the three CSDE1 patients reported by Guo and colleagues
(all carrying the same variant: c.367C>T; p.R123*) did reveal some
similarities but no general consistency (Table 1). ID as well as speech
and motor delay were present in all patients, but this fact is probably
more attributable to the frequency of the symptoms present in CSDE1
in general. In contrast, autism was only present in one patient with
the R123* variant, but in 11 out of 17 patients reported by Guo and
colleagues. Hypotonia and anxiety were each present in three of the
four patients with the R123* variant, some of the other symptoms in
two out of four patients, what makes interpretation difficult. In sum-
mary, more cases would be helpful for further deduction.
Muscle weakness as an explicit clinical symptom has not been
reported for CSDE1 patients previously. However, a possible expla-
nation might be that this clinical finding was mistaken under a hypo-
tonia diagnosis, which is already included in the phenotypic
spectrum of CSDE1 probands. The possibility of an involvement of
CSDE1 in muscle function is supported by the expression of CSDE1
in muscle tissue (Figure 2) but needs certainly further evaluation in
the future using muscle biopsies from CSDE1 patients (if available),
as well as muscular phenotyping of the above-mentioned animal
models and assessment of potential muscle weakness in further
CSDE1-patients in larger studies. Along this line, as long as these
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TABLE 1 Comparison of our patient with the three CSDE1 patients reported by Guo and colleagues, all carrying the same variant: c.367C>T;
p.R123*
Category
Region Simons Simplex Collection California, USA Adelaide, Australia Germany, Essen
Country/ethnicity
information
Caucasian European/Middle-Eastern European Turkey
CSDE1 variant
(NM_001242891)





WES/MIPs WES MIPs trio WES
Mutation inheritance de novo de novo Maternal de novo
Age at last examination
(years)
17 7 19 10




40 38–39 Full term 38
Delivery—mode Vaginal Caesarean section Unknown Vaginal
Birth weight (percentile
and/or SD)
3600 g 3230 g 3400 g 3790 g (93th percentile)
Birth length (percentile
and/or SD)
na 51 cm 51 cm 50 cm (43th percentile)
Birth OFC (percentile
and/or SD)
na unknown 35 cm (98th
percentile)
35 cm (71th percentile)
Infant feeding
difficulties
na Yes Yes Yes, problems chewing and
swallowing small pieces of
food at 2 years
Failure to thrive na No No No
Neurodevelopmental
problems
Autism/autistic features Yes No No No
Intellectual disability Yes Yes Yes Yes
Intellectual quotient
(method, score)
WISC at 17 years: IQ 42 Learning disability Unknown WPPS at 7 years: IQ 45
Childhood speech delay Yes Initially delayed, had speech
therapy, at 2.5 years
words, phrases
Yes Yes, profound (at 10 years
only single word
sentences)




Word loss Unknown na No
Behavior problem
Anxiety (type) Yes Possible, difficult
transitioning, sensor
integration
No Yes, profound (frequently
changing moods, crying
very often as reaction to
anxiety as well as to
happiness)
ADHD (criteria) Yes Yes, receiving medication No No
Repetitive behavior Yes No Yes No
Obsessive–compulsive
behavior
No No Yes No
Aggressive behavior No No No No
Self-injurious behavior Unknown No No No
Bipolar disorder Unknown Unknown Unknown No
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studies are not available, such clinical (even single case) reports are
important for the diagnosing and treating physicians. Nevertheless,
the muscle weakness could also be a consequence of the pyramidal
tract signs and cerebellar symptoms and thus be of neuronal origin.
If this would be the case, one might speculate that one functional
CSDE1 copy is sufficient to maintain muscle function by providing
critical protein level. On a general note, there is a fundamental lack
of data on muscle function in patients with syndromic diseases, who
in almost all cases, show pronounced muscle hypotonia and often
also signs of mild muscle weakness and/or exercise intolerance. Due
to neuromuscular symptoms, these patients may primarily present at
neuromuscular clinics and finding the genetic diagnosis may be ham-
pered by suing NGS panels including only genes involved in neuro-
muscular diseases.
TABLE 1 (Continued)






Muscle weakness Unknown Walked with 16 months,
pedaling with 7 years,
difficulty holding heavy
things, gets “tired,” holds
pencil differently, can swim
Unknown Walked with 3 years
10 months, problems
climbing stairs, able to get
from supine to sitting with
5 years 11 months and up
from floor with 10 years
Muscle hypotonia Yes No Yes Yes, predominantly truncal
hypotonia
Macrocephaly Yes No Yes No
Microcephaly Yes Yes Yes Yes






No Mildly reduced brain volume




space, slim white matter
and a thin and short
corpus callosum with a
partial lack of the splenium




No No Yes No




















59 cm (+3.19SD) 53 cm (77th percentile) at
7.25 years





(onset at age 3 years) with
intermittent bloating
No No No
Short stature No Yes No No
Hand deformity Polydactyly No brachydactyly, some
clinodactyly
No No
Abbreviations: MIPs, molecular inversion probes; na, not applicable; WES, whole exome sequencing; WISC, Wechsler Intelligence Scale for Children;
WPPSI, Wechsler Preschool and Primary Scale of Intelligence; SD, standard deviation.
Source: Table adapted from Guo et al. (2019).
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In addition, our report shows that even if the parents of (neuro-
logical) patients are consanguineous (large homozygous regions
reported in array-based CGH), dominant de novo variants might still
be causative for the manifestation of the underlying phenotype
(Monies et al., 2019) and should therefore be considered in the inter-
pretation of exome datasets.
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